Common use of Split, Subdivision or Combination Clause in Contracts

Split, Subdivision or Combination. If the Company should at any time or from time to time fix a record date for (a) the effectuation of a split or subdivision of the outstanding New Preferred Stock Shares or (b) the determination of Holders of New Preferred Stock Shares entitled to receive a dividend or other distribution payable in additional New Preferred Stock Shares or other securities or rights convertible into, or entitling Holder thereof to receive directly or indirectly, additional New Preferred Stock Shares (hereinafter referred to as the “New Preferred Stock Equivalents”), without payment of any consideration by such holder for the additional New Preferred Stock Shares or New Preferred Stock Equivalents, then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the Exercise Price shall be appropriately decreased and the number of New Preferred Stock Shares which this Warrant is exercisable for, if any, shall be appropriately increased in proportion to such increase of outstanding shares. Notwithstanding the foregoing, in any such case, the aggregate purchase price payable by Holder for the total number of New Preferred Stock Shares (as adjusted) shall remain the same.

Appears in 3 contracts

Samples: Purchase Agreement (Skinmedica Inc), Skinmedica Inc, Skinmedica Inc

AutoNDA by SimpleDocs

Split, Subdivision or Combination. If the Company should at any time or from time to time fix a record date for (a) the effectuation of a split or subdivision of the outstanding New shares of Series A Preferred Stock Shares or (b) the determination of Holders of New Series A Preferred Stock Shares entitled to receive a dividend or other distribution payable in additional New shares of Series A Preferred Stock Shares or other securities or rights convertible into, or entitling Holder thereof to receive directly or indirectly, additional New shares of Series A Preferred Stock Shares (hereinafter referred to as the “New Preferred Stock Series A Equivalents”), without payment of any consideration by such holder for the additional New shares of Series A Preferred Stock Shares or New Preferred Stock Series A Equivalents, then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the Exercise Price shall be appropriately decreased and the number of New shares of Series A Preferred Stock Shares which this Warrant is exercisable for, if any, shall be appropriately increased in proportion to such increase of outstanding shares. Notwithstanding the foregoing, in any such case, the aggregate purchase price payable by Holder for the total number of New shares of Series A Preferred Stock Shares (as adjusted) shall remain the same.

Appears in 1 contract

Samples: Conatus Pharmaceuticals Inc

Split, Subdivision or Combination. If the Company should at any time or from time to time fix a record date for (a) the effectuation of a split or subdivision of the outstanding New shares of Series A-1 Preferred Stock Shares or (b) the determination of Holders holders of New Series A-1 Preferred Stock Shares entitled to receive a dividend or other distribution payable in additional New shares of Series A-1 Preferred Stock Shares or other securities or rights convertible into, or entitling Holder the holder thereof to receive directly or indirectly, additional New shares of Series A-1 Preferred Stock Shares (hereinafter referred to as the “New Preferred Stock Series A-1 Equivalents”), without payment of any consideration by such holder for the additional New shares of Series A-1 Preferred Stock Shares or New Preferred Stock Series A-1 Equivalents, then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the Exercise Price shall be appropriately decreased and the number of New shares of Series A-1 Preferred Stock Shares which this Warrant is exercisable for, if any, shall be appropriately increased in proportion to such increase of outstanding shares. Notwithstanding the foregoing, in any such case, the aggregate purchase price payable by Holder for the total number of New shares of Series A-1 Preferred Stock Shares (as adjusted) shall remain the same.

Appears in 1 contract

Samples: Celladon Corp

Split, Subdivision or Combination. If the Company should at any time or from time to time fix a record date for (a) the effectuation of a split or subdivision of the outstanding New shares of Series B-2 Preferred Stock Shares or (b) the determination of Holders of New Series B-2 Preferred Stock Shares entitled to receive a dividend or other distribution payable in additional New shares of Series B-2 Preferred Stock Shares or other securities or rights convertible into, or entitling Holder thereof to receive directly or indirectly, additional New shares of Series B-2 Preferred Stock Shares (hereinafter referred to as the “New Preferred Stock Series B-2 Equivalents”), without payment of any consideration by such holder for the additional New shares of Series B-2 Preferred Stock Shares or New Preferred Stock Series B-2 Equivalents, then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the Exercise Price shall be appropriately decreased and the number of New shares of Series B-2 Preferred Stock Shares which this Warrant is exercisable for, if any, shall be appropriately increased in proportion to such increase of outstanding shares. Notwithstanding the foregoing, in any such case, the aggregate purchase price payable by Holder for the total number of New shares of Series B-2 Preferred Stock Shares (as adjusted) shall remain the same.

Appears in 1 contract

Samples: GTX Inc /De/

AutoNDA by SimpleDocs

Split, Subdivision or Combination. If the Company should at any time or from time to time fix a record date for (a) the effectuation of a split or subdivision of the outstanding New shares of Series B Preferred Stock Shares or (b) the determination of Holders of New Series B Preferred Stock Shares entitled to receive a dividend or other distribution payable in additional New shares of Series B Preferred Stock Shares or other securities or rights convertible into, or entitling Holder thereof to receive directly or indirectly, additional New shares of Series B Preferred Stock Shares (hereinafter referred to as the “New Preferred Stock Series B Equivalents”), without payment of any consideration by such holder for the additional New shares of Series B Preferred Stock Shares or New Preferred Stock Series B Equivalents, then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the Exercise Price shall be appropriately decreased and the number of New shares of Series B Preferred Stock Shares which this Warrant is exercisable for, if any, shall be appropriately increased in proportion to such increase of outstanding shares. Notwithstanding the foregoing, in any such case, the aggregate purchase price payable by Holder for the total number of New shares of Series B Preferred Stock Shares (as adjusted) shall remain the same.

Appears in 1 contract

Samples: Conatus Pharmaceuticals Inc

Time is Money Join Law Insider Premium to draft better contracts faster.